Seres Therapeutics, Inc. (MCRB) SEC filings
MCRB SEC filings moved a median of -3.23% by the close. MCRB SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MCRB overview →
74 measured MCRB SEC filing events.
Where these MCRB SEC filings landedvs 74 measured MCRB SEC filing reactions
| Middle 50% of MCRB SEC filing reactions | -8.88% to +0.38% |
|---|---|
| Median reaction (to close) | -3.23% |
| Measured reactions | 74 |
Point-in-time · zero look-ahead
Half of the 74 MCRB SEC filing events with a measured close landed between -8.88% and +0.38%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Seres Therapeutics, Inc. | SEC filing · Form EFFECT | +1.11% | +3.33% | |
| Form S-3 Seres Therapeutics, Inc. | SEC filing · Form S-3 | -0.22% | +0.67% | |
| Form 10-Q Seres Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.48% | -0.69% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 05 | SEC filing · Form 8-K | -1.95% | -11.10% | |
| Form 8-K Seres Therapeutics, Inc. For: Jul 31 | SEC filing · Form 8-K | -1.95% | -11.10% | |
| Form S-8 Seres Therapeutics, Inc. | SEC filing · Form S-8 | -1.93% | -9.21% | |
| Form 8-K Seres Therapeutics, Inc. For: Jul 08 | SEC filing · Form 8-K | +0.19% | -9.73% | |
| Form 8-K Seres Therapeutics, Inc. For: Jun 02 | SEC filing · Form 8-K | -6.79% | -15.00% | |
| Form 8-K Seres Therapeutics, Inc. For: May 30 | SEC filing · Form 8-K | -1.57% | -3.81% | |
| Form 10-Q Seres Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.72% | -1.05% | |
| Form 8-K Seres Therapeutics, Inc. For: May 05 | SEC filing · Form 8-K | +2.93% | -0.13% | |
| Form DEF 14A Seres Therapeutics, Inc. For: Jun 09 | SEC filing · Form DEF | +3.89% | -4.83% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | +3.89% | -4.83% | |
| Form 8-K Seres Therapeutics, Inc. For: Mar 16 | SEC filing · Form 8-K | -0.22% | +4.28% | |
| Form 10-K Seres Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +1.34% | |
| Form 8-K Seres Therapeutics, Inc. For: Mar 12 | SEC filing · Form 8-K | +0.00% | +0.56% | |
| Form 8-K Seres Therapeutics, Inc. For: Feb 27 | SEC filing · Form 8-K | +1.51% | +1.03% | |
| Form 10-Q Seres Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.46% | -2.46% | |
| Form 8-K Seres Therapeutics, Inc. For: Nov 05 | SEC filing · Form 8-K | +1.46% | -7.30% | |
| Form 8-K Seres Therapeutics, Inc. For: Sep 23 | SEC filing · Form 8-K | -0.98% | +2.44% | |
| Form 10-Q Seres Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.95% | -6.29% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 06 | SEC filing · Form 8-K | +0.74% | -2.58% | |
| Form 8-K Seres Therapeutics, Inc. For: Jul 17 | SEC filing · Form 8-K | -3.69% | +0.69% | |
| Form 10-Q Seres Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.49% | -2.93% | |
| Form 8-K Seres Therapeutics, Inc. For: May 07 | SEC filing · Form 8-K | -0.82% | -3.04% | |
| Form S-8 Seres Therapeutics, Inc. | SEC filing · Form S-8 | -1.75% | -13.06% | |
| Form 8-K Seres Therapeutics, Inc. For: Apr 21 | SEC filing · Form 8-K | +17.53% | +33.29% | |
| Form 8-K Seres Therapeutics, Inc. For: Apr 10 | SEC filing · Form 8-K | +0.10% | -20.08% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | +2.94% | -5.88% | |
| Form 10-K Seres Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.81% | -0.25% | |
| Form 8-K Seres Therapeutics, Inc. For: Mar 13 | SEC filing · Form 8-K | +1.99% | -6.12% | |
| Form DEF 14A Seres Therapeutics, Inc. For: Mar 13 | SEC filing · Form DEF | -0.20% | +0.19% | |
| Form S-8 Seres Therapeutics, Inc. | SEC filing · Form S-8 | -0.44% | +0.09% | |
| Form PRE 14A Seres Therapeutics, Inc. For: Mar 03 | SEC filing · Form PRE | -0.11% | -7.03% | |
| Form 8-K Seres Therapeutics, Inc. For: Feb 22 | SEC filing · Form 8-K | +2.15% | +4.82% | |
| Form 8-K Seres Therapeutics, Inc. For: Feb 04 | SEC filing · Form 8-K | +0.00% | +0.13% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 13 | SEC filing · Form 8-K | -0.93% | -0.83% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | -3.40% | -6.71% | |
| Form 10-Q Seres Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.12% | -10.70% | |
| Form 8-K Seres Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +1.05% | -9.20% | |
| Form EFFECT Seres Therapeutics, Inc. | SEC filing · Form EFFECT | +2.41% | -1.75% | |
| Form 8-K Seres Therapeutics, Inc. For: Sep 30 | SEC filing · Form 8-K | -2.95% | -4.82% | |
| Form S-3 Seres Therapeutics, Inc. | SEC filing · Form S-3 | -2.95% | -4.82% | |
| Form 8-K Seres Therapeutics, Inc. For: Sep 26 | SEC filing · Form 8-K | -3.44% | +5.62% | |
| Form 8-K Seres Therapeutics, Inc. For: Sep 12 | SEC filing · Form 8-K | +4.83% | -12.73% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | +4.83% | -12.73% | |
| Form DEFM14A Seres Therapeutics, Inc. | SEC filing · Form DEFM14A | -0.27% | -6.49% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 15 | SEC filing · Form 8-K | +0.83% | -1.67% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | +5.75% | +4.56% | |
| Form PREM14A Seres Therapeutics, Inc. For: Aug 15 | SEC filing · Form PREM14A | +0.83% | -1.67% | |
| Form 10-Q Seres Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.16% | -7.94% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 13 | SEC filing · Form 8-K | -5.39% | -12.84% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | -5.39% | -12.84% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.98% | -12.87% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 05 | SEC filing · Form 8-K | -1.98% | -12.87% | |
| Form 8-K Seres Therapeutics, Inc. For: Aug 06 | SEC filing · Form 8-K | -1.84% | +8.11% | |
| Form DEFA14A Seres Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.84% | +8.11% | |
| Form 10-Q Seres Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.15% | +0.44% | |
| Form 8-K Seres Therapeutics, Inc. For: May 08 | SEC filing · Form 8-K | +1.11% | -3.92% | |
| Form 8-K Seres Therapeutics, Inc. For: May 01 | SEC filing · Form 8-K | +1.11% | -3.92% | |
| Form 8-K Seres Therapeutics, Inc. For: Apr 19 | SEC filing · Form 8-K | +0.11% | +18.94% | |
| Form 8-K Seres Therapeutics, Inc. For: Apr 04 | SEC filing · Form 8-K | +3.56% | -1.47% | |
| Form 10-K Seres Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.93% | -0.94% | |
| Form 8-K Seres Therapeutics, Inc. For: Mar 05 | SEC filing · Form 8-K | +0.95% | +0.95% | |
| Form DEF 14A Seres Therapeutics, Inc. For: Mar 05 | SEC filing · Form DEF | -0.89% | -3.62% | |
| Form S-8 Seres Therapeutics, Inc. | SEC filing · Form S-8 | +1.86% | -1.40% | |
| Form 8-K Seres Therapeutics, Inc. For: Feb 24 | SEC filing · Form 8-K | -0.86% | +1.91% | |
| Form PRE 14A Seres Therapeutics, Inc. For: Feb 22 | SEC filing · Form PRE | -0.86% | +1.91% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 30 | SEC filing · Form 8-K | +0.85% | -3.42% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | +0.69% | -16.55% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | -4.08% | -27.04% | |
| Form 8-K Seres Therapeutics, Inc. For: Jan 02 | SEC filing · Form 8-K | -2.27% | -6.99% | |
| Form 10-Q Seres Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.61% | -28.44% | |
| Form 8-K Seres Therapeutics, Inc. For: Nov 02 | SEC filing · Form 8-K | -7.05% | -42.80% |
Keep exploring
More MCRB: earnings → · analyst actions → · MCRB overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Trinity Biotech plc - American Depositary Shares (TRIB) | 292 | -0.13% | 44% |
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
| Chemed Corp (CHE) | 288 | +0.02% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.